From Trump to the FTC: 2017 Dietary Supplement Regulatory Issues to Watch

In the supplemental submission CRN urged FDA to reexamine and correct its interpretation of the drug preclusion clause rather than provide justification for its interpretation

On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”

U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.

What do the new "healthy" label claim definitions mean for consumers and food brands?

The deputy commissioner has been overseeing the reorganization of the FDA's Human Foods Program. He resigned on Monday following the firing of 89 staff members by the Trump Administration.

The new label would complement the Nutrition Label, making important nutrition information readily available for consumers.